A study in premenopausal women with untreated and recently diagnosed SLE demonstrated decreased serum levels of osteocalcin, a marker for bone formation, and increased cross-links excretion in the urine, a marker for bone resorption [21], which finding points to a change in bone metabolism due to the disease itself. The gene discussed is BGLAP; the disease is systemic lupus erythematosus.